Nextdoor Holdings' share price reflects its promising future growth. However, other factors like its balance sheet strength should be considered, especially as the stock trades around its fair value. The company's positive outlook is encouraging for potential investors.
Investors may be overvaluing Nextdoor Holdings given its high P/S ratio and weak projected revenue growth. This could risk share price decline or investors paying an unwarranted premium.
Despite Nextdoor's promising growth outlook, its overvalued stock suggests it may not be the best time for potential investors to buy. Current shareholders may want to consider selling.
In view of the weaker than expected recovery in the ad market, particularly in the financial services and home services vertical markets, CEO Sarah Friar deems the job cuts necessary to 'right-size' the business, despite the tough decision.
The quarter's results showed slowing growth and missed estimates, leading to a negative view. The downturn is seen by some as an investment opportunity, whereas others urge caution due to concerns about the company's valuation, business qualities, and recent quarterly results. Total Weekly Active Users (WAU) miss was a notable worry.
Gainers: •$リペア・セラピューティクス(RPTX.US)$+26.4% (announces worldwide license and collaboration agreement with Roche for camonsertib) •$チューイ A(CHWY.US)$+19.8% (Chewy stock soars on earnings. Here's what really mattered) •$ユーアイパス(PATH.US)$+11.7% ( reported first-quarter revenue growth of 32% year-over-year to $245.1 million) •$ピュア ストレージ A(PSTG.US)$+10.6% (In reaction to earnings) •$クレド テクノロジー グループ(CRDO.US)$+10.2% (In reaction ...
This week, TIME released its 2022 list of the TIME100 Most Influential Companies. Which businesses and corporate leaders are shaping our future? That's the question at the heart of TIME100 Most Influential Companies, an annual list that highlights businesses making an extraordinary impact around the world. To assemble it, TIME solicits nominations across sectors including health care, entertainment, technology, and more from our...
50
10
33
報告
Expendabiggles :
I’ll be honest here. I guess if it “helps” AMC thats fine but time magazine is a lying, fascist rag full of activists disguised as journalists peddling political propaganda and its better off used as toilet paper to wipe your ass. Like cnn but on paper and frankly, its beyond gross. Truth be told, its more like news about AMC helps time sell magazines vs the other way around.
ネクストドア ホールディングス Aに関するコメント
In reaction to earnings/guidance:
• $ウルフスピード(WOLF.US)$ +22.2%, $カナディアン ソーラー(CSIQ.US)$ +6.5%, $BJsホールセール・クラブ・ホールディングス(BJ.US)$ +5.8%, $シスコ システムズ(CSCO.US)$ +5.3%, $キーサイト テクノロジー(KEYS.US)$ +4.3%, $マディソン スクエア ガーデン スポーツ A(MSGS.US)$ +3%, $ネットイーズ(NTES.US)$ +2.7%, $ナイス(NICE.US)$ +2.1%, $シノプシス(SNPS.US)$ + 1.8%
News:
• $ブルージュ エナジー(BROG.US)$ +17.1% (says majority shareholder, BPGIC Holdings, would like to take ...
In reaction to earnings/guidance:
• $トレードデスク A(TTD.US)$+17%, $ワーキバ(WK.US)$ +15.3%, $アーロ テクノロジーズ(ARLO.US)$ +12%, $アレイ テクノロジーズ(ARRY.US)$ +10.3%, $エバーブリッジ(EVBG.US)$ +9.7%, $カタリスト ファーマシューティカルズ(CPRX.US)$ +9.4%, $ハロザイムセラピューティクス(HALO.US)$ +8.7%, $ヴェロ3D(VLD.US)$ +7.6%, $サイバーアーク ソフトウェア(CYBR.US)$ + 6.2%, $ヘモネティクス(HAE.US)$ +5.8%, $ジャクソン フィナンシャル A(JXN.US)$ +5.7% (also increases dividend), $アクソン エンタープライズ(AXON.US)$ +4.8%,...
• $リペア・セラピューティクス(RPTX.US)$ +26.4% (announces worldwide license and collaboration agreement with Roche for camonsertib)
• $チューイ A(CHWY.US)$+19.8% (Chewy stock soars on earnings. Here's what really mattered)
• $ユーアイパス(PATH.US)$ +11.7% ( reported first-quarter revenue growth of 32% year-over-year to $245.1 million)
• $ピュア ストレージ A(PSTG.US)$ +10.6% (In reaction to earnings)
• $クレド テクノロジー グループ(CRDO.US)$ +10.2% (In reaction ...
Which businesses and corporate leaders are shaping our future? That's the question at the heart of TIME100 Most Influential Companies, an annual list that highlights businesses making an extraordinary impact around the world.
To assemble it, TIME solicits nominations across sectors including health care, entertainment, technology, and more from our...
まだコメントはありません